Eckert & Ziegler Strahlen- und Medizintechnik AG
- WKN: 565970
- ISIN: DE0005659700
- Land: Deutschland
Nachricht vom 07.05.2019 | 07:45
Eckert & Ziegler off to a strong start in 2019
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Quarter Results/Quarterly / Interim Statement Berlin, 7 May 2019. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry, increased its sales in the first quarter 2019 by 22 % to EUR 43.5 million year on year. Net income from continuing operations achieved EUR 5.8 million and thus increased by EUR 3.5 million or 152 % year on year. Earnings per share increased by EUR 0.70 to EUR 1.14. The causes of the higher net profit for the year were growth in sales and a more favorable product mix. The greatest spurt of growth was recorded in the Radiopharma segment, which was essentially driven by continuing attractive sales of pharmaceutical radioisotopes to reach a level of EUR 10.0 million, an increase of EUR 3.4 million or 52% year-on-year. The Isotope Products segment also achieved a clear increase in sales of 18% or EUR 4.2 million, reaching a total of EUR 28.2 million. The Radiation Therapy segment, however, recorded a slight drop in sales, achieving EUR 6.4 million, which represents a fall of around 6% year-on-year. The operating cash flow rose significantly by EUR 6.4 million to EUR 7.7 million. Decisive factors here were the increase of EUR 3.5 million in the result for the period and the non-cash effects from the depreciation of assets, which rose by EUR 0.7 million. Overall, cash and cash equivalents as of March 31, 2019 had increased by EUR 5.9 million since the end of 2018, and now amount to EUR 60.1 million. The management is maintaining its projection that an annual surplus of approximately EUR 3.50 per share and sales of approximately EUR 180 million will be achieved. This outlook is based on the assumption that the euro exchange rate does not exceed $ 1.20. The complete financial statements can be viewed here:
07.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | 49 30 941084-138 |
Fax: | 49 30 941084-112 |
E-mail: | karolin.riehle@ezag.de |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 807579 |
End of News | DGAP News Service |
Interaktiv
Weitere News
-
05.12.19 13:43
Eckert & Ziegler Strahlen- und Medizintech ... -
05.12.19 13:25
Eckert & Ziegler Strahlen- und Medizintech ... -
05.12.19 13:13
Eckert & Ziegler Strahlen- und Medizintech ... -
05.12.19 13:00
Eckert & Ziegler Strahlen- und Medizintech ... -
12.11.19 08:50
Eckert & Ziegler: Strong nine-month figures. A ...
GBC-Fokusbox

Media and Games Invest wächst dynamisch und profitabel
Innerhalb des Konzerns Media and Games Invest sind der wachstumsstarke Game-Publisher gamigo AG sowie Unternehmen aus dem dynamischen Bereich „Digital Media“ gebündelt. Der Wachstumskurs der Gesellschaft soll sowohl auf Basis eines anhaltenden anorganischen Wachstums sowie durch den Ausbau des bestehenden Geschäftes fortgesetzt werden. Im Rahmen unserer Initial-Coverage-Studie haben wir ein Kursziel von 1,90 € je Aktie ermittelt und vergeben das Rating KAUFEN..
Der AKTIONÄR News

15. Dezember 08:30 Mit Hebel zum Erfolg - was Anleger über Faktor-Zertifikate wissen ...
15. Dezember 07:00 Brennstoffzelle auf Erfolgskurs
14. Dezember 17:54 1.000 Euro Weihnachtsgeld verdienen?
14. Dezember 16:00 Amazon, Walt Disney, LVMH, Adidas: So geht es weiter
14. Dezember 15:59 Nach ArQule und Loxo Oncology: Ist AKTIONÄR-Tipp Deciphera das ...
News im Fokus

Vonovia SE: Wohnungsunternehmen Vonovia erhält erstmalig A- Rating (News mit Zusatzmaterial)
13. Dezember 2019, 10:50
Aktuelle Research-Studie

MBH Corporation Plc
Original-Research: MBH Corporation plc (von GBC AG): Management Interview
13. Dezember 2019